Genotype and phenotype of apolipoprotein E in Alzheimer patients in Castille and Leon (Spain);Genotipo y fenotipo de la apolipoproteina E en enfermos de Alzheimer en Castilla y Leon

Neurologia

Volumn 12, Issue 9, 1997, Pages 384-388

  Cacho, J ^a,c   Brenas T ^a   Gonzalez C ^b   Arroyo, T ^a   Arcaya, J ^a   Garcia R ^a   Guerrero, A L ^a   Navajo, J A ^a   Garcia C ^a   Gonzalez Buitrago J M ^b  

^a Servicio de Bioquímica

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Apoliprotein E. Alzheimer's disease; Genotype; Phenotype

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; MALE; PHENOTYPE; PROTEIN DETERMINATION; SPAIN;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE;

EID: 13144293095     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. American Psychiatric Association, Committee on Nomenclature and Statistic. Diagnostic and statistical manual of mental disorders 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987.
2. Katzman R, Kawas C. The epidemiology of dementia and Alzheimer disease. En: Terry RD, Katzman R, Bick L, editores. Alzheimer disease. Nueva York: Raven Press, 1994; 105-122.
3. Roses A. Alzheimers disease and apolipoprotein genotypes: a new paradigm for clinical dementia evaluations. Madrid: SEN, 1996; 11-13.
4. Corder EH, Saunders AM, Strittmatter W, Schnechel DE, Gaskel PC, Small GW et al. Gene dose of apolipoprotein E type IV allele and the risk of Alzheimer's Disease in late onset families. Science 1993; 261: 921-923.
5. Tsuda T, López B, Rogaeva A, Freedman M, Rogacv EA, Drachman D et al. Are the associations between Alzheimer's disease and polymorphisms in apolipoprotein E and the apolipoprotein CII genes due to linkage desequilibrium? Ann Neurol 1994; 36: 97-100.
6. Siest G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz, J, Geltean MM et al. Apolipoprotein E: An important gene and protein to follow in laboratory medicine: Clin Chem 1995; 41: 1.068-1.086.
7. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's Disease. Lancet 1993; 342: 697-699.
8. Uchihara T, Duyckaerts C, He Y, Kobayashy K, Seilhean D, Amouyel P et al. ApoE inmunoreactivity and microglial cell in Alzheimer's disease brain. Neurosci Lett 1995; 195: 5-8.
9. Wisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Current Opin Lipido 1994; 5: 110-116.
10. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. Stable expresion and secretion of apolipoprotein E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 1995, 270: 27.063-27.071.
11. Hyman BT, West HL, Rebeck GW, Lai F, Mann DM. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol 1995; 52: 373-378.
12. Nathan BP, Chang KC, Bellosta S, Brich E, Ge N, Mahley RW et al. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymeration. J Biol Chem 1995, 270: 19.791-19.799.
13. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Gen 1996; 14: 55-91.
14. McKhaann G, Drachman M, Folstein M, Katzman R, Price D, Stadien EM. Clinical diagnosis of Alzheimer's disease: report of the NINCS-ADRDA work group under the auspicius of Departament of health and Human Services Task force of Alzheimer's disease. Neurology 1984; 34: 939-944.
15. Mayeux R, Stern Y, Ottman R, Thomas K, Tatemichi, Ming-Xin T et al. The apolipoprotein E-4 allele in patients with Alzheimer's Disease. Ann Neurol 1993; 34: 752-754.
16. Galasco D, Sitoh T, Xia Y, Thai LJ, Katzman R, Hi LR et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer disease. Neurology 1994; 44: 1.950-1.951.
17. Polivikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi S et al. Apolipoprotein E, dementia and cortical deposition of b-amyloid protein. N Engl J Med 1995; 333: 1.242-1.247.
18. Clair DS, Norman J, Perry R, Yaates C, Wilcock G, Brookes A. Apolipoprotein E-4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994; 176: 45-46.
19. Itoh Y, Yamada M. Apolipoprotein E and the neuropathology of dementia. Lancet 1996; 342: 599-600.
20. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37: 254-259.
21. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994; 145: 1.472-1.484.
22. Osuntokun BO, Sahota A, Ogunniyi AO. Lack of an association between apolipoprotein E-4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 1995; 38: 463-465.
23. Hackler R, Schäfer JR, Motzny S, Kleineto G, Haffarnick H, Steinmmetz A et al. Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using Phast System and immunofixation. J Lipid Res 1994; 35: 153-158.
24. Saunders AM, Hulette C, Welsh-Bohmer KA, Schmechel DE, Grain B, Burke JR et al. Specifity, sensivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease. Lancet 1996; 342: 90-93.
25. Gearing M, Mina SS, Hedreen JC, Sumi SM, Hansen LE, Heiman A. The consortion to Stablish a Registry for Alzheimer's (CERAD). Neuropathology confirmation of the clinical diagnosis of Alzheimer's. Neurology 1995; 45: 461-466.
26. Farrer LA, Brin MF, Elsas LE, Goate A, Kennedy J, Mayeux R et al. Consensus statment. Statment of use of apolipoprotein E testing for Alzheimer disease. ACMG/ASHG Working Group on Apo-E and Alzheimer disease. JAMA 1995; 274: 1.627-1.629.
27. Reiman EM, Caseli RJ, Yun LS, Chen K, Brandy D, Minoshima S et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the E-4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758.